VentriPoint Diagnostics Ltd (VPT) - Total Liabilities
Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has total liabilities worth CA$5.03 Million CAD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
VentriPoint Diagnostics Ltd - Total Liabilities Trend (2005–2024)
This chart illustrates how VentriPoint Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
VentriPoint Diagnostics Ltd Competitors by Total Liabilities
The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Barunson Co. Ltd
KQ:018700
|
Korea | ₩13.18 Billion |
|
Varopakorn Public Company Limited
BK:VARO
|
Thailand | ฿886.04 Million |
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM3.56 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$771.99K |
|
Westgate Energy Inc.
V:WGT
|
Canada | CA$22.21 Million |
|
NOWVERTICAL GROUP INC.
F:5XQ
|
Germany | €39.52 Million |
|
Leeuwin Metals Ltd
AU:LM1
|
Australia | AU$2.35 Million |
Liability Composition Analysis (2005–2024)
This chart breaks down VentriPoint Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 13.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how VentriPoint Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for VentriPoint Diagnostics Ltd (2005–2024)
The table below shows the annual total liabilities of VentriPoint Diagnostics Ltd from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$3.64 Million | +114.91% |
| 2023-12-31 | CA$1.69 Million | +19.01% |
| 2022-12-31 | CA$1.42 Million | +17.54% |
| 2021-12-31 | CA$1.21 Million | -61.56% |
| 2020-12-31 | CA$3.15 Million | +13.17% |
| 2019-12-31 | CA$2.78 Million | +93.35% |
| 2018-12-31 | CA$1.44 Million | -56.84% |
| 2017-12-31 | CA$3.34 Million | +14.16% |
| 2016-12-31 | CA$2.92 Million | +19.31% |
| 2015-12-31 | CA$2.45 Million | -15.17% |
| 2014-12-31 | CA$2.89 Million | -25.62% |
| 2013-12-31 | CA$3.88 Million | +1.49% |
| 2012-12-31 | CA$3.83 Million | -19.83% |
| 2011-12-31 | CA$4.77 Million | +86.28% |
| 2010-12-31 | CA$2.56 Million | -26.05% |
| 2009-12-31 | CA$3.46 Million | +53.25% |
| 2008-12-31 | CA$2.26 Million | +278.51% |
| 2007-12-31 | CA$597.11K | +6161.83% |
| 2006-12-31 | CA$9.54K | +67.67% |
| 2005-12-31 | CA$5.69K | -- |
About VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provid… Read more